Huffman, TX, United States of America

Alan Anthony Galuska

This inventor holds 28 USPTO granted patents and 15 published patent applications and 7 EPO patents. Top assignees: Exxonmobil Chemical Patents Inc., Exxonmobil Research and Engineering Company, Exxonmobil Upstream Research Company. Active years: 2009-2026.

USPTO Granted Patents = 28 

% Patents Active = 78.6

 

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 81(Granted Patents)


Location History:

  • Glen Gardener, NJ (US) (2009 - 2010)
  • Glen Gardner, NJ (US) (2011 - 2014)
  • Huffman, TX (US) (2013 - 2024)
  • Ellijay, GA (US) (2022 - 2024)

Company Filing History:


Years Active: 2009-2026

Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents

Title: The Innovative Journey of Alan Anthony Galuska

Introduction: Alan Anthony Galuska, a talented inventor hailing from Huffman, Texas, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Alan Anthony Galuska holds several patents in various fields, including renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Alan Anthony Galuska has worked tirelessly to bring his ideas to life. His passion for innovation has led to the development of cutting-edge solutions that have positively impacted numerous industries.

Collaborations: Throughout his career, Alan Anthony Galuska has collaborated with leading research institutions, universities, and tech companies to further enhance his inventions. These partnerships have allowed him to push the boundaries of innovation and create groundbreaking technologies.

Conclusion: Alan Anthony Galuska's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true pioneer in the world of inventions. His work continues to inspire future generations of inventors to dream big and create a better tomorrow.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…